The participant which took the 1st place in this rating is by aggregate opinion of all three respondent groups is the best choice in 2023, the absolute recommendation of #1 in the category “The drug for the treatment of liver diseases and biliary tract”.
Using this rating is only possible with
This rating was built as a result of the study of social preferences in
2023,
under the “Favorites of Success” Contest in Ukraine and it’s the free information.
In case of full or partial republishing of the information drawn from this rating,
it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications,
or put an active hyperlink to this page in the electronic media.
Participants of the contest (not excluding the leader) can also freely use this information in their news, press releases, reports and other PR-communications.
However, it should be understood that the image of the contest awards, such like “Favorite of Success – 2023” medal,
which is awarded to the winners at the annual awards ceremony, as well as official winner status &mdashl is the registered Trademarks, and
their use requires permission, license.
Participating in public events and contest receiving the award at the annual holiday show, and/or
obtaining an official permission to use the medal image from the event organizer,
the Contest winners proving support which allows to Contest to implement its activities on
public opinion research with the annual publication of ratings in free access. Together with the license
winner receives a number of additional benefits, including massive PR-campaign in mass media (on the Internet, in the press and on TV).
Leader of this rating has an opportunity to get benefits of the rights and privileges of winner,
the “Absolute Favorite”. The winner may be represented in the status of the
best choice in the category “
The drug for the treatment of liver diseases and biliary tract”,
and receive an award, a gold medal
“Favorite of Success – 2023”, on an annual
awards ceremony, along with the right to use its image in the advertising and labeling.
Details…